Toxicology Letters 181 (2008) 140 Download full-text
Contents lists available at ScienceDirect
journal homepage: www.elsevier.com/locate/toxlet
Corrigendum to “Regulation of gamma-H2AX and securin contribute
to apoptosis by oxaliplatin via a p38 mitogen-activated protein
kinase-dependent pathway in human colorectal cancer cells”
[Toxicol. Lett. 179 (June(2)) (2008) 63–70]
S.-J. Chiu∗, J.-I. Chao, Y.-J. Lee, T.-S. Hsu
Tzu Chi University, College of Life Sciences, Department of Life Science, 701, Section 3, Chung-Yang Road, Hualien 970, Taiwan
The authors regret that they have incorrectly cited a recent publication in Cancer Treatment Reviews entitled “Oxaliplatin for the
treatment of cisplatin-resistant cancer: a systematic review”, Stordal, B., Pavlakis, N., Davey, R., 2007. Cancer Treatment Reviews 33(4),
347–357, and have significantly misrepresented the Stordal et al. findings.
To correct the error will require the removal of one sentence from the introduction and one sentence from the Discussion.
In the Introduction, on the first page, the fourth line, the following sentence should be removed “Oxaliplatin has been widely accepted
as potentially useful for the treatment of cisplatin-resistant cancer (Stordal et al., 2007).”
In the Discussion, on the fifth page, 2nd paragraph, third line, the following sentence should be removed “Oxaliplatin has been reported
to be useful for the treatment of cisplatin-resistant cancer (Stordal et al., 2007).”
The authors of the cited article have also provided a Letter to the Editor that explains their view.
DOIs of original articles:10.1016/j.toxlet.2008.04.004, 10.1016/j.toxlet.2008.07.003
∗Corresponding author. Tel.: +886 3 8565301; fax: +886 3 8572526.
E-mail address: email@example.com (S.-J. Chiu).
0378-4274/$ – see front matter © 2008 Elsevier Ireland Ltd. All rights reserved.